ABT

Abbott Laboratories

ABT · Salud · Next earnings: 21 Oct 2026 · Before the open · Q3 2026

Relevance 54/100 · Minor

1-year price history

Source: Yahoo Finance

The chart uses daily closes adjusted by the available provider. There may be delays, gaps or differences versus the official source.

Company

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

Sector Healthcare · Medical Devices
Website https://www.abbott.com

What the market expects

ConsensusPrior-year EPS

EPS1.421.30

Revenue12,994,335,690—

23 analysts

How expectations have moved

Expectations: Neutral

Expectativas neutrales: cotiza un 27% por debajo de su máximo de 52 semanas.

Stock, 90 days: +4.6%

Prior behaviour

Average absolute move: 7.4%
Largest move: 10.7%
releases with a move larger than 5%: 75%
beat the EPS consensus in: 2 of the last 4

Quarter Date 1-session move Surprise EPS

Jun 2026 16 Jul 2026 +10.7% +2.3%

Mar 2026 16 Apr 2026 -6.0% +0.9%

Dec 2025 22 Jan 2026 -10.0% +0.0%

Sep 2025 15 Oct 2025 -2.9% +0.0%

Historical moves describe typical magnitude, not a future direction.

Expected move

±6.3% (options)

“±X%” is the typical move size, not a forecast of direction.

Stock situation

Price: 98.73
30 days: -8.9%
90 days: +4.6%
Distance to 52-week high: -26.9%
Market cap: 169,854,419,000

Metrics to watch

Ventas del fármaco o producto principal
Guidance de ingresos anual
Avances de pipeline / ensayos clínicos mencionados
Margen operativo
BPA e ingresos frente al consenso (sorpresa)
Cambio en el guidance respecto al trimestre anterior
Reacción del mercado frente al movimiento histórico y al implícito

Relevance breakdown

market_cap: 13.4
analyst_coverage: 9.2
estimate_revisions: 0.3
recent_price_move: 3.5
historical_earnings_vol: 11.1
sector_importance: 4.0
recent_news_coverage: 7.0

Disclaimer

Radar Acciones provides information and analysis tools, not personalised investment advice. Consensus and expectations data describe the setup around an event with objective figures; they must never be read as a forecast of direction or price.